Find

Centre for Faecal Microbiota Transplantation - CEFTA

Publications

Sort by: Date | Author | Title

Bahl, M. I., Jørgensen, S. M. D., Skriver, A. H., Larsen, N. A., Wang, M., Licht, T. R., Dahlerup, J. F. & Hvas, C. L. (2020). Faecal microbiota transplantation for eradication of co-infection with Clostridioides difficile and extensively drug-resistant KPC-producing Klebsiella pneumoniae. Scandinavian Journal of Gastroenterology, 55(5), 626-630. https://doi.org/10.1080/00365521.2020.1753806

Baunwall, S. M. D., Lee, M. M., Eriksen, M. K., Mullish, B. H., Marchesi, J. R., Dahlerup, J. F. & Hvas, C. L. (2020). Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis. EClinicalMedicine, 29-30, Article 100642. https://doi.org/10.1016/j.eclinm.2020.100642

Jørgensen, S. M. D., Hvas, C. L., Dahlerup, J. F., Mikkelsen, S., Ehlers, L., Hammeken, L. H., Licht, T. R., Bahl, M. I. & Erikstrup, C. (2019). Banking feces: a new frontier for public blood banks? Transfusion, 59(9), 2776-2782. https://doi.org/10.1111/trf.15422

Dehlholm-Lambertsen, E., Hall, B. K., Jørgensen, S. M. D., Jørgensen, C. W., Jensen, M. E., Larsen, S., Jensen, J. S., Ehlers, L., Dahlerup, J. F. & Hvas, C. L. (2019). Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection. Therapeutic Advances in Gastroenterology, 12, Article 1756284819843002. https://doi.org/10.1177/1756284819843002

Grosen, A. K., Povlsen, J., Lemming, L. E., Dahl Jørgensen, S. M., Dahlerup, J. F. & Hvas, C. L. (2019). Faecal Microbiota Transplantation Eradicated Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae from a Renal Transplant Recipient with Recurrent Urinary Tract Infections. Case Reports in Nephrology and Dialysis, 9(2), 102-107. https://doi.org/10.1159/000502336

Hvas, C. L., Jørgensen, S. M. D., Jørgensen, S. P., Storgaard, M., Lemming, L., Hansen, M. M., Erikstrup, C. & Dahlerup, J. F. (2019). Fecal Microbiota Transplantation is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection. Gastroenterology, 156(5), 1324-1332.e3. https://doi.org/10.1053/j.gastro.2018.12.019

Keller, J. J., Vehreschild, M. JGT., Hvas, C. L., Jørgensen, S. MD., Kupciskas, J., Link, A., Mulder, C. JJ., Goldenberg, S. D., Arasaradnam, R., Sokol, H., Gasbarrini, A., Hoegenauer, C., Terveer, E. M., Kuijper, E. J. & Arkkila, P. (2019). Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug. United European Gastroenterology Journal, 7(10), 1408-1410. https://doi.org/10.1177/2050640619887579

Hvas, C. L., Bendix, M., Dige, A., Dahlerup, J. F. & Agnholt, J. (2018). Current, experimental, and future treatments in inflammatory bowel disease: a clinical review. Immunopharmacology and Immunotoxicology, 40(6), 446-460. https://doi.org/10.1080/08923973.2018.1469144

Hvas, C. L., Ott, P., Paine, P., Lal, S., Jørgensen, S. P. & Dahlerup, J. F. (2018). Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature. World Journal of Gastroenterology, 24(21), 2320-2326. https://doi.org/10.3748/wjg.v24.i21.2320

Dahl Jørgensen, S. M., Erikstrup, C., Dinh, K. M., Lemming, L. E., Dahlerup, J. F. & Hvas, C. L. (2018). Recruitment of feces donors among blood donors: Results from an observational cohort study. Gut Microbes, 9(6), 540-550. https://doi.org/10.1080/19490976.2018.1458179

Hvas, C. L., Farrer, K., Blackett, B., Lloyd, H., Paine, P. & Lal, S. (2018). Reduced 30-day gastrostomy placement mortality following the introduction of a multidisciplinary nutrition support team: a cohort study. Journal of Human Nutrition and Dietetics, 31(3), 413-421. https://doi.org/10.1111/jhn.12520

Hvas, C. L., Borre, M. & Fassov, J. (2017). Ernæring og kosttilskud ved kronisk inflammatorisk tarmsygdom. Ugeskrift for Læger, 179(22), 2-6. http://ugeskriftet.dk/videnskab/ernaering-og-kosttilskud-ved-kronisk-inflammatorisk-tarmsygdom

Jørgensen, S. M. D., Hansen, M. M., Erikstrup, C., Dahlerup, J. F. & Hvas, C. L. (2017). Faecal microbiota transplantation: establishment of a clinical application framework. European Journal of Gastroenterology and Hepatology, 29(11), 36-45. https://doi.org/10.1097/MEG.0000000000000958

Hvas, C. L., Dige, A., Bendix Rasch, M., Wernlund, P. G., Christensen, L. A., Dahlerup, J. F. & Agnholt, J. (2016). Casein glycomacropeptide for active distal ulcerative colitis: a randomized pilot study. European Journal of Clinical Investigation, 46(6), 555-63. https://doi.org/10.1111/eci.12634

Oppfeldt, A. M., Dahlerup, J. F., Christensen, L. A. & Hvas, C. L. (2016). Faecal microbiota transplantation for recurring Clostridium difficile infection in a patient with Crohn's disease and ileorectal anastomosis. BMJ Case Reports, 2016. https://doi.org/10.1136/bcr-2016-217209

Hvas, C. L. (2016). Fæcestransplantation: afføring fra raske donorer som behandling af akutte og kroniske sygdomme. Månedsskrift for Almen Praksis, 94(3), 203-211.

Ravnborg, A. B., Hvas, C. L., Agnholt, J., Dahlerup, J. F., Vind, I., Till, A., Rosenstiel, P. & Höllsberg, P. (2009). Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways. Clinical and Experimental Immunology, 155, 487-95.

Hvas, C. L., Kelsen, J., Agnholt, J., Höllsberg, P., Tvede, M., Møller, J. K. & Dahlerup, J. F. (2007). Crohn's disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria. Scandinavian Journal of Gastroenterology, 42, 592-601.

Hvas, C. L. (2007). Modulation of cellular immune responses by bacterial products. Implications for Crohn's disease.

Kelsen, J., Hvas, C. L., Agnholt, J. & Dahlerup, J. F. (2006). CD4⁺CD25⁺-regulatoriske T-celler og deres betydning for sygdomme hos mennesker. Ugeskrift for Læger, 168, 32-7.

Displaying results 21 to 40 out of 40

2

Revised 10.01.2025

-

CEFTA web editor